January 31, 2018 / 7:01 AM / 6 months ago

BRIEF-Sartorius Stedim Biotech FY EBITDA Up At ‍​294.9 Million Euros

Jan 31 (Reuters) - SARTORIUS STEDIM BIOTECH SA:

* FY EBITDA EUR ‍​294.9 MILLION VERSUS EUR 288.7 MILLION YEAR AGO

* FY NET PROFIT FOR THE PERIOD EUR ‍​ 180.4 MILLION VERSUS EUR 176.6 MILLION YEAR AGO

* FY SALES REVENUE EUR ‍​1.08 BILLION VERSUS EUR 1.05 BILLION YEAR AGO

* CAPEX IS EXPECTED TO BE AT APPROX. 15% OF SALES‍​

* FOR 2018 FORECASTS A RISE IN SALES REVENUE BY ABOUT 7% TO 10% AND AN INCREASE OF THE UNDERLYING EBITDA MARGIN BY APPROX. 0.5 PERCENTAGE POINTS OVER THE PRIOR-YEAR FIGURE OF 27.3%

* FROM 2018, US TAX REFORM TO MAKE GROUP´S TAX RATE FALL BY ABOUT 2 PERCENTAGE POINTS TO 26% Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below